Research theme for competitive and other funds (8)：
2022 - 2025 Functions of the cholangiocarcinoma suppressor gene extracted from printing company workers' samples: From cell cycle regulation to drug discovery
2022 - 2024 科研費 基盤C
2019 - 2023 地元大阪の印刷所労働者胆管がん組織を使ったがん遺伝子の探索:創薬基盤の構築
2019 - 2021 科研費 基盤C
2015 - 2019 Genetic risk verification of juvenile-onset cholangiocarcinoma
2015 - 2018 科研費 基盤C
2007 - 2009 Analysis of idiopathic portal hypertension
2007 - 2009 科研費 若手B
Show all
Papers (91)：
Etsushi Kawamura, Tsutomu Matsubara, Norifumi Kawada. New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma. Cancers. 2023. 15. 15
Yoshinari Matsumoto, Hideki Fujii, Mika Harima, Haruna Okamura, Yoshimi Yukawa-Muto, Naoshi Odagiri, Hiroyuki Motoyama, Kohei Kotani, Ritsuzo Kozuka, Etsushi Kawamura, et al. Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease. Nutrients. 2023. 15. 5. 1175-1175
Naoshi Odagiri, Akihiro Tamori, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Sawako Uchida-Kobayashi, Masaru Enomoto, Norifumi Kawada. A case of hepatocellular carcinoma with "pseudoprogression" followed by complete response to atezolizumab plus bevacizumab. Clinical journal of gastroenterology. 2023
Kohei Kotani, Masaru Enomoto, Sawako Uchida-Kobayashi, Akihiro Tamori, Yoshimi Yukawa-Muto, Naoshi Odagiri, Hiroyuki Motoyama, Ritsuzo Kozuka, Etsushi Kawamura, Atsushi Hagihara, et al. Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis. Journal of gastroenterology. 2023
Ritsuzo Kozuka, Akihiro Tamori, Masaru Enomoto, Yoshimi Muto-Yukawa, Naoshi Odagiri, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, et al. Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort. Journal of viral hepatitis. 2022
2001 - 2005 Osaka City University Graduate School of Medicine
1993 - 1999 Kawasaki Medical School
Professional career (1)：
博士(医学) (大阪市立大学大学院医学研究科)
Awards (5)：
2022/09 - APASL oncology Investigator award In Vitro Study on the Function of Sloan Kettering Institute Gene in Suppression of Intrahepatic Cholangiocarcinoma Growth
